AstraZeneca (AZN) Plummets 5.86%, Market Cap Shrinks by $15.2 Billion
By ATTN Desk · Editorial oversight: Sean Han
AstraZeneca (NYS: AZN) shares closed at $178.1959, down 5.86% from the previous day, reducing its market capitalization by approximately $15.29817 billion to $276.35911 billion.[1] A decline of this magnitude in a single trading session delivers an immediate blow to shareholder value and constitutes volatility that necessitates position reassessments by both institutional and retail investors.[1]
On that day, AZN’s trading volume stood at 4,165,630 shares.[1] Although comparative volume data was not disclosed, given that the market capitalization shrank by nearly double digits in billions rather than a simple percentage drop in one day, this movement could influence short-term risk perceptions and liquidity management for the stock.[1]
| Category | Value |
|---|---|
| Closing Price | $178.1959 |
| Change Rate | -5.86% |
| Market Capitalization | $276.35911 billion |
| Market Cap Change | -$15.29817 billion |
| Trading Volume | 4,165,630 shares |